Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.
about
Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives.Angiogenesis: Managing the Culprits behind Tumorigenesis and MetastasisCharacterization of neutralizing antibodies reacting with the 213-224 amino-acid segment of human galectin-9Galectins in Cancer and Translational Medicine: From Bench to Bedside
P2860
Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.
@en
Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.
@nl
type
label
Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.
@en
Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.
@nl
prefLabel
Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.
@en
Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.
@nl
P2093
P2860
P50
P356
P1476
Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.
@en
P2093
Enrique Gallego-Colon
Iga Grochoła
Marcin Kubeczko
Natalia Ruiz-Agamez
P2860
P356
10.3390/IJMS19010210
P407
P5008
P577
2018-01-10T00:00:00Z